Pria was founded in 2002 to bring the benefits of fluorescent clinical diagnostics into point-of-care and consumer markets. Since founding, the company has developed a novel diagnostics platform and built its first product Element. In addition to Pria´s internal development efforts, the Company has on-going collaborations with top tier universities as well as working as a sub-contractor on DARPA and NIH grant programs.
Pria is currently evaluating partnership and licensing opportunities using its NanoFL™ platform in diagnostics applications addressing autoimmune diseases, infectious diseases, bioweapons, industrial screening and environmental monitoring. For more information on partnership opportunities, please contact Business Development.
Pria is a privately-held, privately-funded medical device company. For investor information, please contact Investor Relations.